Growth • Pfizer
PFE
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
4,2%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
1,4%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
-13,2%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
-13,3%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
-0,5%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
0,2%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!